Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Ride Therapeutics secures up to $7.3 million from the Cystic Fibrosis Foundation to advance next-generation genetic medicines.

PRIVATESep 10, 2026•about 2 hours ago

Amount Raised

$7.3 Million

Round Type

Venture - Series Unknown

CambridgeBiotechnologyHealth CareTherapeutics

Investors

Cystic Fibrosis Foundation

Description

Ride Therapeutics has announced an investment of up to $7.3 million from the Cystic Fibrosis Foundation. The funding will be used to advance the development of next-generation genetic medicines. This investment underscores the Foundation's commitment to supporting innovative therapies for cystic fibrosis. The collaboration aims to bring significant advancements in treatment options.

Company Information

Company

Ride Therapeutics

Location

Cambridge, Massachusetts, United States

About

Ride Therapeutics is focused on developing next-generation genetic medicines. The company aims to advance therapies for cystic fibrosis and similar genetic conditions. It is leveraging innovative technologies to improve treatment outcomes. The investment from the Cystic Fibrosis Foundation will support their research and development efforts.

Don't miss Ride Therapeutics's next move

Get an email the moment Ride Therapeutics raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Ride Therapeutics's next move

See what Strategic adds

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Ride Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.